Purchases and Sales Made in Q3 2024 in Madrigal Pharmaceuticals, Inc. (MDGL)
This table provides information about the institutional ownership of Madrigal Pharmaceuticals, Inc. (MDGL) during Q3 2024. The information is specifically focused on institutions that hold shares of MADRIGAL PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 08, 2024
Q3 2024
|
Alp Invest Partners B.V.
Amsterdam, P7 |
SELL
|
- |
-42.3K- 50.0% |
$8.98M - $12.4M
|
42.3K
$14.6M
|
|
|
Oct 29, 2024
Q3 2024
|
Emerald Mutual Fund Advisers Trust
|
SELL
|
- |
-54.1K- 71.37% |
$11.5M - $15.8M
|
21.7K
$7.49M
|
|
|
Nov 14, 2024
Q3 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-67.6K- 81.13% |
$14.4M - $19.8M
|
15.7K
$5.43M
|
|
|
Oct 29, 2024
Q3 2024
|
Emerald Advisers, LLC
|
SELL
|
- |
-69.5K- 71.82% |
$14.7M - $20.4M
|
27.3K
$9.41M
|
|
|
Nov 14, 2024
Q3 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-100K- 66.72% |
$21.2M - $29.3M
|
49.9K
$17.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-125K- 14.56% |
$26.5M - $36.6M
|
734K
$253M
|